The protection of trade secrets has been on the European legislator’s agenda since 2011. It was felt that the lack of harmonisation in this field is very disadvantageous for cross-border innovation in Europe. After the initial report requested...

New rules in the FCA’s policy statement on Guaranteed Asset Protection (GAP) insurance (PS15/13) are about to change the way GAP insurance sold alongside the sale of a motor vehicle (add-on GAP Insurance) is sold to both consumers and commerci...

...

The DPC has published useful guidance on CCTV usage for controllers. The guidance is intended to assist owners and occupiers of premises to understand their responsibilities and obligations regarding data protection when using CCTV. This is particul...

While fines recently imposed by the French and UK data protection supervisory authorities have been high, the supervisory authorities in Germany have so far imposed rather moderate penalties. This could now be changed by a new model for calculating ...

Court of appeal overturns High Court judgment in Lloyd v Google LLC [2019] EWCA Civ 1599 Court of Appeal judgment The Court of Appeal has given the go-ahead for a representative claim to be served on Google LLC in the U.S. for alleged data breaches,...

Summary On 7 November 2019 the EDPS issued guidance on how to determine who is a controller, processor and joint controller. The EDPS is an independent supervisory authority whose primary objective is to ensure EU institutions and bodies respect the...

President Cyril Ramaphosa has received a request from the Information Regulator Chairperson to declare that the remaining provisions of the Protection of Personal Information Act (POPIA) commence on 1 April 2020. If the President acts on the Informa...

How does the communication within a team take place in the home office? Due to the increasing intensity of preventive measures against the spread of corona, more and more companies are closing down their locations and, where possible, relocating bus...

Introduction Following the declaration by the World Health Organisation (WHO) on 30 January of a Public Health Emergency of International Concern (PHEIC) in response to the coronavirus crisis (please see our last briefing here), the vi...

Introduction Following the declaration by the World Health Organisation (WHO) on 30 January of a Public Health Emergency of International Concern (PHEIC) in response to the coronavirus crisis (please see our last briefing here), the vi...

(MENAFN - CDN Newswire) A report added to the rich database of MarketsandResearch.biz , titled [To enable links in your articles, contact MENAFN Cl... ......

In late February, China expelled three Wall Street Journal correspondents after the newspaper’s publication of an opinion column that Beijing condemned as racist. ......

The mining sector in Africa is facing radical change as youth activists take action against the environmental degradation caused by mining industries. Tensions between activists and the mining industry have raised, however, concerns over human rights abuses. Kenya’s National Coalition for Human Rights Defenders reported, for instance, cases of harassment and intimidation “against at least […]

The post Growing Youth Activism for Environmental Protection in Africa appeared first on Inter Press Service.

[Dalsan Radio] The United States Embassy in Mogadishu calls on the Somali Government and people to allow and encourage transparent reporting on the impact of the COVID-19 pandemic to facilitate the critical efforts to protect and preserve the health and safety of the people of Somalia.

In the lead-up to the Truth Matters conference in October, we will be focusing our attention on the sufficiency, authority, and clarity of Scripture. Of our previous blog series, none better embodies that emphasis than Frequently Abused Verses. The following entry from that series originally appeared on February 10, 2016. -ed.

Next week will mark the second anniversary of Jamie Coots’s death. He was a father, pastor, and one of the stars of the National Geographic Channel’s reality series, Snake Salvation. The show followed Coots’s life and ministry as a prominent leader in a sect of Holiness Pentecostals who incorporate handling poisonous snakes into their worship in fulfilment of the promise of supernatural power and protection in Mark 16:17-18.

Coots died from a snakebite.

Snake handling—once popular throughout the Appalachian states—has dwindled to a tiny subculture of Pentecostals who believe in the practice of the extreme signs and wonders described in Mark 16:17-18. Specifically, they teach that they have the ability to cast out demons, speak in tongues, handle poisonous snakes, drink poison, and heal the sick (they also expose themselves to open flames, although that particular sign is not included in Mark’s gospel). And every couple years, the movement garners headlines because another pastor or congregant has died attempting to fulfill those supposed promises.

Virtually all other charismatics would disavow such extreme behavior, while holding just as tightly to the promises conveyed in the closing verses of Mark’s gospel—albeit more selectively.

For example, charismatic prosperity preacher Benny Hinn cites the passage in defense of his faith-healing ministry: “I knew the Lord had told me to pray for the sick as part of preaching the gospel, just as He told the disciples, in Mark 16:18: ‘They will lay hands on the sick, and they will recover.’” ^[1] Benny Hinn, The Anointing (Nashville: Thomas Nelson, 1997) 49.

And in his book When Heaven Invades Earth, Bill Johnson—pastor of Bethel Redding, one of the most influential charismatic churches in the country—points to the end of Mark’s gospel as a promise of God’s ongoing miraculous work.

As our ministry teams travel around the world, we have come to expect certain things. Healing, deliverance, and conversions are the fruits of our labors. While healing is seldom the subject we teach on, it is one of the most common results. As we proclaim the message of the Kingdom of God, people get well. The Father seems to say, Amen! To His own message by confirming the word with power (see Mark 16:20). ^[2] Bill Johnson, When Heaven Invades Earth (Shippensburg, PA: Treasure House, 2003) 89.

We could go on with examples of how charismatics of various traditions lean heavily on the closing verses of Mark’s gospel, but you get the point. For many it’s a foundational passage—one that explicitly promises all believers the power to perform signs and wonders.

But is that really the point of the passage? And more importantly, do those verses even belong in your Bible to begin with? Even a simple reading of the text raises some significant questions about its Scriptural authenticity.

Now after He had risen early on the first day of the week, He first appeared to Mary Magdalene, from whom He had cast out seven demons. She went and reported to those who had been with Him, while they were mourning and weeping. When they heard that He was alive and had been seen by her, they refused to believe it. After that, He appeared in a different form to two of them while they were walking along on their way to the country. They went away and reported it to the others, but they did not believe them either. Afterward He appeared to the eleven themselves as they were reclining at the table; and He reproached them for their unbelief and hardness of heart, because they had not believed those who had seen Him after He had risen. And He said to them, “Go into all the world and preach the gospel to all creation. He who has believed and has been baptized shall be saved; but he who has disbelieved shall be condemned. These signs will accompany those who have believed: in My name they will cast out demons, they will speak with new tongues; they will pick up serpents, and if they drink any deadly poison, it will not hurt them; they will lay hands on the sick, and they will recover.” So then, when the Lord Jesus had spoken to them, He was received up into heaven and sat down at the right hand of God. And they went out and preached everywhere, while the Lord worked with them, and confirmed the word by the signs that followed. [And they promptly reported all these instructions to Peter and his companions. And after that, Jesus Himself sent out through them from east to west the sacred and imperishable proclamation of eternal salvation.] (Mark 16:9-20)

As you can see, there are actually two endings to Mark’s gospel contained in the above quote. Verses 9-20 are referred to as the longer ending, while the portion in brackets at the end of verse 20 is called the shorter ending—on its own it would appear immediately after verse 8. Both have appeared individually in a variety of translations—the NASB includes both.

But neither ending appears in the earliest and most reliable New Testament manuscripts. No ancient book has been more carefully preserved than the Bible—we have several thousand manuscripts, with some dating all the way back to mere decades after they were first written. And through the science of textual analysis, scholars have determined that the final verses of Mark were not in the original, inspired text.    

On top of that, as John MacArthur explains in his commentary on the passage, there are also several internal indications that Mark didn’t write either ending.

First, the transition between verse 8 and verse 9 is awkward and disjointed. The conjunction now (from the Greek word de) implies continuity with the preceding narrative, but the focus of verse 9 abruptly shifts to Mary Magdalene rather than continuing a discussion of the women referred to in verse 8. Moreover, it would be strange for Mark to wait until the end of his narrative to introduce Mary Magdalene, as if for the first time . . . when she was already mentioned three times in the prior context (Mark 15:40, 47, 16:1). A similar discontinuity regards Peter, who is singled out in verse 7 yet not mentioned again in verses 9-20. The “shorter ending” . . . attempts to rectify those incongruities by highlighting both Peter and the other women. . . . But this shorter ending has even weaker manuscript evidence to support it than the longer ending.

Second, the vocabulary, style, and structure of the longer ending is not consistent with the rest of Mark’s gospel. There are eighteen words in this section that are not used elsewhere in Mark. For example, the title “Lord Jesus” is used here (v. 19) but is never used anywhere else in Mark’s account.

Third, the inclusion of apostolic signs does not fit the way the other three gospels conclude their accounts of the resurrection and ascension of Jesus Christ. Though many signs mentioned in this section parallel portions of the book of Acts (cf. Acts 2:4; 9:17; 10:46; 28:8), some are clearly without biblical support, such as being able to “pick up” venomous “serpents” (though perhaps loosely based on Paul’s experience in Acts 28:3-5) or “drink any deadly poison.” ^[3] John MacArthur, The MacArthur New Testament Commentary: Mark 9-16 (Chicago: Moody Publishers, 2015) 411-412.

Summing up the case against the scriptural credentials of Mark 16:9-20, John MacArthur writes,

The evidence, both external and internal, conclusively demonstrates that verses 9-20 were not originally part of Mark’s inspired record. While they generally summarize truths taught elsewhere in the New Testament, they should always be evaluated in light of the rest of Scripture. No doctrines or practices should be established solely on them. The snake-handling preachers of the Appalachians provide a prime example of the errors that can arise from accepting these verses as authoritative.

Nonetheless, knowing that Mark 16:9-20 is not original should give believers more confidence in the accuracy of the New Testament, not less. As noted above, the science of textual analysis makes it possible for biblical scholars to identify the very few passages that were not part of the original. Such places are clearly marked in modern translations, making it easy for students of Scripture to identify them. Consequently, believers can approach the rest of the text with the settled assurance that the Bible they hold in their hands accurately reflects the original. ^[4] The MacArthur New Testament Commentary: Mark 9-16, 412.

That conclusion then begs the question: Where did these verses come from?

Most likely, they were added in by a scribe who felt Mark’s original ending was missing something. However, it does not appear that he was so audacious as to concoct an ending from his own imagination. Instead, Mark 16:9-20 is a patchwork quilt of other biblical passages concerning the life of Christ after His resurrection, His commissioning of the apostles, and stories from their ministry in the founding of the church.

Time and space don’t permit me to break down the probable origin of each verse, but let me encourage you to listen to John MacArthur’s sermon on the passage, called “The Fitting End to Mark’s Gospel,” or consult his commentary on Mark 9-16 for more details on how this extrabiblical passage was likely assembled.

And what of Mark’s original ending? Why was it deemed so deficient in the first place? True, it is abrupt and to the point: “They went out and fled from the tomb, for trembling and astonishment had gripped them; and they said nothing to anyone, for they were afraid” (Mark 16:8). But as John MacArthur explains, that abrupt ending perfectly fits both Mark’s style and his purpose for writing at all.

Mark’s ending is abrupt but it is not incomplete. The tomb was empty; the angelic announcement explained that Jesus had risen; and multiple eyewitnesses confirmed those events. The purpose of Mark’s gospel was to demonstrate that Jesus is the Christ, the Son of God (Mark 1:1). Having amply made that point, no further proof was necessary.

Throughout his gospel, Mark consistently punctuated key events in the life of the Lord Jesus by emphasizing the wonder He evoked in the hearts and minds of others. Mark simply moves from one point of amazement about Christ to the next. So the narrative ends where it ought to end. It climaxes with amazement and bewilderment at the resurrection of the crucified Savior (cf. John 20:31). In so doing, it leaves the reader in a place of wonder, awe, and worship, centered on its glorious subject: the Lord Jesus Christ, the Son of God. ^[5] The MacArthur New Testament Commentary: Mark 9-16, 417-418.

So while Mark 16:9-20 may be a significant proof text for many charismatics, their interpretation is invalidated when we understand that those verses never belonged in Scripture to begin with.

Prague Daily Monitor

Starting today, the city requests that all people using Prague public transport to wear protection across their nose and mouth. Also, the Mayor of Prague Zdeněk Hřib recommended to stores that they insist that customers cover their face and nose as well.

read more

Farhana Haque Rahman is Senior Vice President of IPS Inter Press Service; a journalist and communications expert, she is a former senior official of the United Nations Food and Agriculture Organization and the International Fund for Agricultural Development.

The post Press Freedom Needs Protection from Pandemic too appeared first on Inter Press Service.

Millions of families who were already poor and vulnerable before the COVID-19 outbreak face impossible decisions about food, healthcare, and survival. We have a responsibility to act immediately and protect those most in need.

Approved project 43407-017 in Philippines.

This brief presents recommendations to further encourage public-private partnerships for the environmental protection industry in the People's Republic of China, as the country seeks to address the negative impact of rapid urbanization.

Social protection, especially health care systems for the poor, is essential to reduce inequality.

The head of the International Monetary Fund on Friday signaled a possible downward revision of global economic forecasts, and warned the United States and China against rekindling a trade war that could weaken a recovery from the coronavirus pandemic.

A long-standing hypothesis suggests the BCG vaccine also serves to generally enhance the immune system, meaning it could protect against covid-19, and trials are under way to find out

Title: Time to Remind Teens About Sun Protection
Category: Health News
Created: 4/25/2010 10:10:00 AM
Last Editorial Review: 4/26/2010 12:00:00 AM

ABSTRACT

Anti-galactose-α-1,3-galactose (anti-α-Gal) antibody is naturally expressed at a high level in humans. It constitutes about 1% of immunoglobulins found in human blood. Here, we designed a live attenuated influenza virus vaccine that can generate α-Gal epitopes in infected cells in order to facilitate opsonization of infected cells, thereby enhancing vaccine-induced immune responses. In the presence of normal human sera, cells infected with this mutant can enhance phagocytosis of human macrophages and cytotoxicity of NK cells in vitro. Using a knockout mouse strain that allows expression of anti-α-Gal antibody in vivo, we showed that this strategy can increase vaccine immunogenicity and the breadth of protection. This vaccine can induce 100% protection against a lethal heterosubtypic group 1 (H5) or group 2 (mouse-adapted H3) influenza virus challenge in the mouse model. In contrast, its heterosubtypic protective effect in wild-type or knockout mice that do not have anti-α-Gal antibody expression is only partial, demonstrating that the enhanced vaccine-induced protection requires anti-α-Gal antibody upon vaccination. Anti-α-Gal-expressing knockout mice immunized with this vaccine produce robust humoral and cell-mediated responses upon a lethal virus challenge. This vaccine can stimulate CD11b^lo/– pulmonary dendritic cells, which are known to be crucial for clearance of influenza virus. Our approach provides a novel strategy for developing next-generation influenza virus vaccines.

IMPORTANCE Influenza A viruses have multiple HA subtypes that are antigenically diverse. Classical influenza virus vaccines are subtype specific, and they cannot induce satisfactory heterosubtypic immunity against multiple influenza virus subtypes. Here, we developed a live attenuated H1N1 influenza virus vaccine that allows the expression of α-Gal epitopes by infected cells. Anti-α-Gal antibody is naturally produced by humans. In the presence of this antibody, human cells infected with this experimental vaccine virus can enhance several antibody-mediated immune responses in vitro. Importantly, mice expressing anti-α-Gal antibody in vivo can be fully protected by this H1N1 vaccine against a lethal H5 or H3 virus challenge. Our work demonstrates a new strategy for using a single influenza virus strain to induce broadly cross-reactive immune responses against different influenza virus subtypes.

Key Points

ABSTRACT

Bezlotoxumab is a human monoclonal antibody against Clostridium difficile toxin B, indicated to prevent recurrence of C. difficile infection (rCDI) in high-risk adults receiving antibacterial treatment for CDI. An exploratory genome-wide association study investigated whether human genetic variation influences bezlotoxumab response. DNA from 704 participants who achieved initial clinical cure in the phase 3 MODIFY I/II trials was genotyped. Single nucleotide polymorphisms (SNPs) and human leukocyte antigen (HLA) imputation were performed using IMPUTE2 and HIBAG, respectively. A joint test of genotype and genotype-by-treatment interaction in a logistic regression model was used to screen genetic variants associated with response to bezlotoxumab. The SNP rs2516513 and the HLA alleles HLA-DRB1*07:01 and HLA-DQA1*02:01, located in the extended major histocompatibility complex on chromosome 6, were associated with the reduction of rCDI in bezlotoxumab-treated participants. Carriage of a minor allele (homozygous or heterozygous) at any of the identified loci was related to a larger difference in the proportion of participants experiencing rCDI versus placebo; the effect was most prominent in the subgroup at high baseline risk for rCDI. Genotypes associated with an improved bezlotoxumab response showed no association with rCDI in the placebo cohort. These data suggest that a host-driven, immunological mechanism may impact bezlotoxumab response. Trial registration numbers are as follows: NCT01241552 (MODIFY I) and NCT01513239 (MODIFY II).

IMPORTANCE Clostridium difficile infection is associated with significant clinical morbidity and mortality; antibacterial treatments are effective, but recurrence of C. difficile infection is common. In this genome-wide association study, we explored whether host genetic variability affected treatment responses to bezlotoxumab, a human monoclonal antibody that binds C. difficile toxin B and is indicated for the prevention of recurrent C. difficile infection. Using data from the MODIFY I/II phase 3 clinical trials, we identified three genetic variants associated with reduced rates of C. difficile infection recurrence in bezlotoxumab-treated participants. The effects were most pronounced in participants at high risk of C. difficile infection recurrence. All three variants are located in the extended major histocompatibility complex on chromosome 6, suggesting the involvement of a host-driven immunological mechanism in the prevention of C. difficile infection recurrence.

Subjects with low serum HDL cholesterol levels are reported to be susceptible to diabetes, with insulin resistance believed to be the underlying pathological mechanism. Apolipoprotein M (apoM) is a carrier of sphingosine-1-phosphate (S1P), a multifunctional lipid mediator, on HDL, and the pleiotropic effects of HDL are believed to be mediated by S1P. In the current study, we attempted to investigate the potential association between apoM/S1P and insulin resistance. We observed that the serum levels of apoM were lower in patients with type 2 diabetes and that they were negatively correlated with BMI and the insulin resistance index. While deletion of apoM in mice was associated with worsening of insulin resistance, overexpression of apoM was associated with improvement of insulin resistance. Presumably, apoM/S1P exerts its protective effect against insulin resistance by activating insulin signaling pathways, such as the AKT and AMPK pathways, and also by improving the mitochondrial functions through upregulation of SIRT1 protein levels. These actions of apoM/S1P appear to be mediated via activation of S1P1 and/or S1P3. These results suggest that apoM/S1P exerts protective roles against the development of insulin resistance.

A long-standing hypothesis suggests the BCG vaccine also serves to generally enhance the immune system, meaning it could protect against covid-19, and trials are under way to find out

Shuttered stores worsened Montreal-based company’s already struggling business

Dr David Nabarro, the WHO's Covid-19 envoy, said that people would need to become accustomed to a "new reality".

NationAction

The post Demand Protections for People on the Front Lines appeared first on The Nation.

Follow our live coronavirus updates HERE Coronavirus: the symptoms

The company has made steps to secure meetings against Zoombombing

Workers say the supermarket giant is not providing them with the best possible protection against coronavirus after their complaints were dismissed by the head office.

Montreal-based shoe chain Aldo Group is seeking protection from its creditors in Canada, the United States and Europe because of disruptions caused by COVID-19.

Unemployment and coronavirus: How do European countries protect jobs?

Today, Chairs of the House Committees that oversee the Department of Health and Human Services (HHS) voiced their strong opposition to a harmful Trump Administration rule that would roll back Affordable Care Act (ACA) nondiscrimination protections. In a letter, House Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ), House Ways and Means Committee Chairman Richard E. Neal (D-MA), House Education and Labor Committee Chairman Bobby Scott (D-VA), and House Oversight and Reform Committee Chairwoman Carolyn B. Maloney (D-NY) urged HHS Secretary Alex Azar not to finalize this troubling rule and to instead focus on responding to the COVID-19 pandemic. The rule would overturn core protections for marginalized communities including LGBTQ+ people, women, individuals with limited English proficiency, and individuals with disabilities, and eliminate many health care programs and activities from coverage of the Affordable Care Act’s nondiscrimination requirements. “At a time when the United States is grappling with the 2019 coronavirus (COVID-19) pandemic and access to health care services is so critical, we are disappointed that this Administration is once again taking steps to limit access to health care and embolden discrimination against some of the most vulnerable among us,” the Chairs wrote. “If finalized, this dangerous rule would open the door to discrimination against patients in express contradiction to the plain language and intent of the law, and would therefore be illegal. Undermining protections for marginalized individuals at any time is unacceptable, but it is particularly egregious to do so during the worst global pandemic in over a century.” Read the full letter to Secretary Azar HERE. ###

Washington, D.C. – Consumer Protection and Commerce Subcommittee Chair Jan Schakowsky (D-IL) and Ranking Member Cathy McMorris Rodgers (R-WA) today announced that the Subcommittee will hold a teleconference forum on Monday, May 11, at 12 p.m. (EDT) with Federal Trade Commission (FTC) Chairman Joseph J. Simons to discuss critical consumer protection issues related to the COVID-19 pandemic. “The COVID-19 pandemic has brought about significant consumer protection concerns that fall under the purview of the FTC, including COVID-19 related scams, price gouging, privacy and data security issues, and more,” Schakowsky and McMorris Rodgers said.  “We look forward to hearing from Chairman Simons about the steps FTC is taking to ensure consumers are protected during this pandemic.”      This forum is open to the press.  Credentialed reporters interested in listening to the forum live should RSVP to Evan.Gilbert@mail.house.gov by 5 pm on Friday, May 8.   ###

The U.S. Food and Drug Administration posted a photo:

This product is promoted with unapproved claims to prevent, treat, mitigate, or cure COVID-19. FDA warns consumers to avoid unproven and potentially unsafe products. See the Warning Letter for more information:

www.fda.gov/inspections-compliance-enforcement-and-crimin...

More information is available at www.fda.gov/consumers/health-fraud-scams/fraudulent-coron...

Photo by FDA's Office of Regulatory Affairs, Health Fraud Branch

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to FDA's Office of Regulatory Affairs, Health Fraud Branch is appreciated but not required.

The U.S. Food and Drug Administration posted a photo:

This product is promoted with unapproved claims to prevent, treat, mitigate, or cure COVID-19. FDA warns consumers to avoid unproven and potentially unsafe products. See the Warning Letter for more information:

www.fda.gov/inspections-compliance-enforcement-and-crimin...

More information is available at www.fda.gov/consumers/health-fraud-scams/fraudulent-coron...

Photo by FDA's Office of Regulatory Affairs, Health Fraud Branch

This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to FDA's Office of Regulatory Affairs, Health Fraud Branch is appreciated but not required.

An employee of a Sewell, N.J., company that provided temporary electrical utilities pleaded guilty today to participating in a fraud conspiracy at an Environmental Protection Agency (EPA)-designated Superfund site in New Jersey.

Invista will pay a $1.7 million civil penalty and spend up to an estimated $500 million to correct self-reported environmental violations discovered at facilities in seven states. The company disclosed more than 680 violations of water, air, hazardous waste, emergency planning and preparedness, and pesticide regulations to EPA after auditing 12 facilities it acquired from DuPont in 2004.

The co-owner of a Martinsville, N.J., landscaping company pleaded guilty to participating in a fraud conspiracy at the Environmental Protection Agency (EPA)-designated Superfund site, Federal Creosote, located in Manville, N.J. Frederick Landgraber pleaded guilty in the U.S. District Court of New Jersey today to one count of conspiracy to defraud the EPA from approximately March 2002 until approximately June 2005 at the Federal Creosote site.

A former executive of Bennett Environmental Inc. (BEI), a Canadian-based company that treats and disposes of contaminated soil, pleaded guilty to participating in a conspiracy to pay kickbacks and commit fraud at the U.S. Environmental Protection Agency (EPA)-designated Superfund site, Federal Creosote, located in Manville, N.J. The former executive also pleaded guilty to participating in a money laundering conspiracy and impeding a proceeding before the U.S. Securities and Exchange Commission.

The United States has filed a lawsuit to bar a married couple’s alleged nationwide tax fraud scheme involving so-called asset protection.

A Newark grand jury indicted three individuals for their participation in fraud and kickback conspiracies related to contracts at a U.S. Environmental Protection Agency (EPA)-designated Superfund site, Federal Creosote, located in Manville, N.J.

A federal judge in St. George, Utah, has permanently enjoined Kent Bickmore, the founder of a so-called asset-protection business, from helping customers file fraudulent liens and create hidden nominee bank accounts

The Department released a new video aimed at educating employers about worker rights and employer responsibilities under the anti-discrimination provision of the Immigration and Nationality Act.